BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 26766850)

  • 1. Screening for cognitive dysfunction in Huntington's disease with the clock drawing test.
    Terwindt PW; Hubers AA; Giltay EJ; van der Mast RC; van Duijn E
    Int J Geriatr Psychiatry; 2016 Sep; 31(9):1013-20. PubMed ID: 26766850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clock Drawing Test and the diagnosis of amnestic mild cognitive impairment: can more detailed scoring systems do the work?
    Rubínová E; Nikolai T; Marková H; Siffelová K; Laczó J; Hort J; Vyhnálek M
    J Clin Exp Neuropsychol; 2014; 36(10):1076-83. PubMed ID: 25486502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clock Drawing Test for dementia of the Alzheimer's type: A comparison of three scoring methods in a memory disorders clinic.
    Brodaty H; Moore CM
    Int J Geriatr Psychiatry; 1997 Jun; 12(6):619-27. PubMed ID: 9215942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive Screening Tests in Huntington Gene Mutation Carriers: Examining the Validity of the Mini-Mental State Examination and the Montreal Cognitive Assessment.
    Ringkøbing SP; Larsen IU; Jørgensen K; Vinther-Jensen T; Vogel A
    J Huntingtons Dis; 2020; 9(1):59-68. PubMed ID: 31658065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clock-drawing: is it the ideal cognitive screening test?
    Shulman KI
    Int J Geriatr Psychiatry; 2000 Jun; 15(6):548-61. PubMed ID: 10861923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor dysfunction influence on executive functioning in manifest and premanifest Huntington's disease.
    Hart EP; Dumas EM; Schoonderbeek A; Wolthuis SC; van Zwet EW; Roos RA
    Mov Disord; 2014 Mar; 29(3):320-6. PubMed ID: 24500841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of two brief screening measures of cognitive impairment in Huntington's disease.
    Mickes L; Jacobson M; Peavy G; Wixted JT; Lessig S; Goldstein JL; Corey-Bloom J
    Mov Disord; 2010 Oct; 25(13):2229-33. PubMed ID: 20721924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity and reliability of the clock drawing test as a screening tool for cognitive impairment in patients with fibromyalgia.
    Can SS; Gencay-Can A; Gunendi Z
    Compr Psychiatry; 2012 Jan; 53(1):81-6. PubMed ID: 21571264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clock-drawing test in vascular mild cognitive impairment: Validity of quantitative and qualitative analyses.
    Dong F; Shao K; Guo S; Wang W; Yang Y; Zhao Z; Feng R; Wang J
    J Clin Exp Neuropsychol; 2020 Aug; 42(6):622-633. PubMed ID: 32700636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of the Parkinson's disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington's disease.
    Martinez-Horta S; Horta-Barba A; Perez-Perez J; Sampedro F; de Lucia N; De Michele G; Kehrer S; Priller J; Migliore S; Squitieri F; Castaldo A; Mariotti C; Mañanes V; Lopez-Sendon JL; Rodriguez N; Martinez-Descals A; Garcia-Ruiz P; Júlio F; Januário C; Delussi M; de Tommaso M; Noguera S; Ruiz-Idiago J; Sitek EJ; Nuzzi A; Pagonabarraga J; Kulisevsky J;
    J Neurol; 2020 May; 267(5):1527-1535. PubMed ID: 32030521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Reliability of Clock Drawing Test Scoring Systems Modeled on the Normative Data in Healthy Aging and Nonamnestic Mild Cognitive Impairment.
    Mazancova AF; Nikolai T; Stepankova H; Kopecek M; Bezdicek O
    Assessment; 2017 Oct; 24(7):945-957. PubMed ID: 26933141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clock drawing test and questionable dementia: reliability and validity.
    Seigerschmidt E; Mösch E; Siemen M; Förstl H; Bickel H
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1048-54. PubMed ID: 12404654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypokinesia in Huntington's disease co-occurs with cognitive and global dysfunctioning.
    Reedeker N; Van Der Mast RC; Giltay EJ; Van Duijn E; Roos RA
    Mov Disord; 2010 Aug; 25(11):1612-8. PubMed ID: 20629165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Freund Clock Drawing Test as a screening tool to detect cognitive dysfunction in elderly cancer patients undergoing comprehensive geriatric assessment.
    Lycke M; Ketelaars L; Boterberg T; Pottel L; Pottel H; Vergauwe P; Goethals L; Van Eygen K; Werbrouck P; Debruyne D; Derijcke S; Borms M; Ghekiere V; Wildiers H; Debruyne PR
    Psychooncology; 2014 Oct; 23(10):1172-7. PubMed ID: 24729471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of six clock-drawing test scoring methods in a nursing home.
    Chen L; Xu S; Jin X; Lu X; Liu L; Lou Y; Wang Y; Li Y; Jin Y
    Aging Clin Exp Res; 2018 Jul; 30(7):775-781. PubMed ID: 29022271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clock drawing interpretation scale (CDIS) and neuro-psychological functions in older adults with mild and moderate cognitive impairments.
    Colombo M; Vaccaro R; Vitali SF; Malnati M; Guaita A
    Arch Gerontol Geriatr; 2009; 49 Suppl 1():39-48. PubMed ID: 19836615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the Freund clock drawing test within the Mini-Cog as a screening tool for cognitive impairment in elderly patients with or without cancer.
    Ketelaars L; Pottel L; Lycke M; Goethals L; Ghekiere V; Santy L; Boterberg T; Van Den Noortgate N; Pottel H; Debruyne PR
    J Geriatr Oncol; 2013 Apr; 4(2):174-82. PubMed ID: 24071542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive Dysfunction Contributes to Mobility Impairments in Huntington's Disease.
    Kloos AD; Kegelmeyer DA; Fritz NE; Daley AM; Young GS; Kostyk SK
    J Huntingtons Dis; 2017; 6(4):363-370. PubMed ID: 29254103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of the Montreal Cognitive Assessment in the detection of cognitive dysfunction in Huntington's disease.
    Bezdicek O; Majerova V; Novak M; Nikolai T; Ruzicka E; Roth J
    Appl Neuropsychol Adult; 2013; 20(1):33-40. PubMed ID: 23373682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing impairment of executive function and psychomotor speed in premanifest and manifest Huntington's disease gene-expansion carriers.
    Unmack Larsen I; Vinther-Jensen T; Gade A; Nielsen JE; Vogel A
    J Int Neuropsychol Soc; 2015 Mar; 21(3):193-202. PubMed ID: 25850430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.